Safety and Efficacy of Sofosbuvir with Ribavirin® in Hepatitis C, Genotype 3 Patients with Cirrhosis: A Real-world Experience

Introduction Hepatitis C virus (HCV) is the leading cause of cirrhosis. The advent of Directly Acting Antivirals (DAAs) like Sofosbuvir (SOF) has dramatized the treatment and is the cornerstone for the treatment of HCV. Most trials have been conducted in HCV genotype 1 (GT-1) and data for Interferon...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cureus
Main Authors: Butt, Nazish, Akbar, Ali, Abbasi, Amanullah, Reema, Sehrish, Baqar, Jaffer Bin, Shaikh, Qurban Hussain
Format: Artigo
Jezik:Inglês
Izdano: Cureus 2019
Teme:
Internal Medicine
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6450597/
https://ncbi.nlm.nih.gov/pubmed/31001466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4012
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki